A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2

By Singh M.   Carlson J.R.   Briones M.   Ugozzoli M.   Kazzaz J.   Barackman J.   Ott G.   O'Hagan D.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1822-1827

Elsevier

Access to resources Recommend Favorite

The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice

By Cataldo D.M.   Van Nest G.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1710-1715

Elsevier

Access to resources Recommend Favorite

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice

By Higgins D.A.   Carlson J.R.   Van Nest G.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 478-484

Elsevier

Access to resources Recommend Favorite

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

By Heineman T.C.   Clements-Mann M.L.   Poland G.A.   Jacobson R.M.   Izu A.E.   Sakamoto D.   Eiden J.   Van Nest G.A.   Hsu H.H.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2769-2778

Elsevier

Access to resources Recommend Favorite

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59

By Barchfeld G.L.   Van Nest G.   Ott G.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1557-1562

Elsevier

Access to resources Recommend Favorite